Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea
This study has been completed.
Otsuka Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
First received: January 25, 2010
Last updated: January 9, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||February 2011|
|Primary Completion Date:||January 2011 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Received:||January 9, 2012|